TNF-alpha as therapeutic target in NASH: tried, but not yet proven.
Chitturi
Shivakumar
S
Farrell
Geoffrey C
GC
D000818:Animals; D005234:Fatty Liver / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D006505:Hepatitis / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D006801:Humans; D008099:Liver / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D008103:Liver Cirrhosis / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism / Q000473:pathology; D009336:Necrosis; D010431:Pentoxifylline / Q000494:pharmacology / Q000627:therapeutic use*; D020011:Protective Agents / Q000494:pharmacology / Q000627:therapeutic use*; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*
D020011:Protective Agents; D014409:Tumor Necrosis Factor-alpha; D010431:Pentoxifylline